A skilled professional with a wealth of experience across all healthcare markets and disease areas.
I am an expert in market access, quick to identify innovative ways to expand and grow the market, solution focused with a commercially focused on deliverables for both NHS and industry.
I work quickly to identify the needs of my customers and the priorities in the NHS and align these with the commercial drivers of my organisation.
An expert on policy, I endeavour to address unmet need.
I am very able in managed entry as well as established products.
My time working nationally has given me a large network of key opinion leaders who have chosen me as a preferred industry partner. This includes Third Parties, Societies and patient groups.
I have been successful in complex service reconfiguration nationally , as well as shaping throughput locally.
Successful in delivering sales and outcomes I have been a mentor for my colleagues as well as Brand and Market Access champion.
To expand my knowledge further I have undertook a Post graduate accredited module with Sheffield University School of Health Related Research on Health Technology Assessment. I am also preparing for my Prince2 Foundation.
Originally, a nurse in Heamo Oncology I have experience of working in the NHS within a London teaching hospital as well as fifteen years experience in the industry.
I endeavour to make the patient pathway seamless; whilst creating quicker access to our medicines.
I also hold a US and British Passport.
Senior Market Access Consultant @ Working with the Pharma industry and their Payers, Curo enables an innovative and collaborative approach to Market Access for branded therapies.
Gaining Market Access is vital to a therapy’s success, although of course the story doesn’t end here. Market Access is not just about getting your therapy approved for use or reimbursement; it’s about enabling Payers at Regional level to understand its impact in real, measurable terms - how a therapy can be best fit into Treatment pathways, seeing how a therapy performs clinically or financially against KPIs, and of course, how it will impact on patients. At a local level, Market Access is about ensuring prescribers know when to prescribe in order to ensure optimum clinical and value performance, and to show the impacts – both positive and negative - of prescribing one treatment over another.
The Market Access process tends to focus solely on gaining National approval when in actual fact, this is just the start. MA extends further to Regional approval which in turn enables usage. It’s also worth remembering here that Regional Payers have KPIs and drivers of their own and although a drug may be approved on a National basis, if it doesn’t fit a Payer’s needs, it just won’t be prescribed.
Curo services support a therapy the entire way through the healthcare system, from initial National listing to the professionals at the front of healthcare – the prescribers. Curo uses several concepts and approaches (based on our experiences within the Health Care sector and with Payers) that enable Pharma companies to work right from end to end, ensuring that they can address each individual aspect of the process with intelligence.
- See more at: https://www.curo.co.uk/our-services#sthash.dGlOPAOe.dpuf From December 2015 to Present (1 month) Market Access Manager @ Market Acess for Orphan diseases and speciality medicine From 2014 to April 2015 (1 year) Oncology Healthcare Access Manager @ Market Access for Astellas Oncology From April 2013 to January 2014 (10 months) london, united kingdomHealthcare Development Manager @ Strategically covered London health economy. Expert in the development of pathways and reconfiguration of services.
I led a National defence strategy for team, which has since been rolled out across Europe.
I provides solutions for greater uptake through third parties and academia, including the Royal College of Physicians.
Specialist in market expansion by identifying new ways for patient throughput.Leader in market access From April 2011 to April 2013 (2 years 1 month) london, united kingdomNational Healthcare Business Manager @ Leading on Strategic Funding and Capacity
A national role delivering projects across Roches entire Oncology portfolio.
Expert on funding streams within the Oncology Healthcare Sector. Leader om Funding and Capacity.
Knowledge and Experience includes:
Managed entry for sixteen new licences within oncology
Specialised commissioning
Academic science networks
Societies
Cancer Outcomes
Cancer Drugs Fund
Independent Sector
NHS Commissioning Board
Programme Budgeting Data
Service Redesign
Third parties and policy development
NICE uptake and variations
Managed entry
End of Life Strategy
Clinical Trials
National Clinical Audit
Top Up Policy
Regarded highly by my colleagues and customers From March 2007 to January 2011 (3 years 11 months) Healthcare Development Manager @ Worked with three Cancer Networks on NICE uptake, managed entry and audit of performance.
Received an Unlocking Potential Award for my contribution to the uptake of Herceptin Adjuvant by addressing the capacity issues with solutions within our oral treatments.
Developed Health Economic around service redesign to ensure every patient could receive a Roche medicine.
Successful with Individual Funding Applications for Roche Non Approved Medicines.
Effective Horizon Scanning for portfolio
Involvement with tumour working boards for new licences including presentations on estimation for populations. From February 2004 to February 2007 (3 years 1 month) Healthcare Manager @ Region of the year for two years. MAT Growth 39.3%
Audited over 1500 patients at risk of falls and osteoporosis
Partnered with Crawley PCT with audit reviewing all patients in care homes. Developed assessment tools with KOL and secured new funding.
Secured several PCT formulary inclusions, which contributed to the teams success.
PDG for house bounds on Isle of Wight, targeting these patients. Organised processes including supply and labelling. Due to this the sales on the Island were growing at 112% MAT compared to national MAT of 37%
Set up screening projects across PCTs in therapy areas generating more business opportunity.
Hard to access customers
Postcard projects for fallers via Ambulances services recommending high dose calcium and vitamin D with a business opportunity of 200+ patients. From March 2002 to March 2004 (2 years 1 month)
Nursing, Registered Nursing/Registered Nurse @ King's College London, U. of London From 1993 to 1996 Felixstowe Ladies College Arabella Sargent is skilled in: Health Economics, Diabetes, Pharmacy, Clinical Trials, Pharmacoeconomics, Gastroenterology, Medical Writing, Clinical Research, Neurology, Pharmacovigilance, Cancer, Market Access, Medicine, Pharmaceutics, Psychiatry, Medical Affairs, Product Launch